A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars

Ocular and urogenital infections with Chlamydia trachomatis (C.t.) are caused by a range of different serovars. The first C.t. vaccine in clinical development (CTH522/CAF®01) induced neutralizing antibodies directed to the variable domain 4 (VD4) region of major outer membrane protein (MOMP), coveri...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Anja Weinreich, Rosenkrands, Ida, Holland, Martin J., Andersen, Peter, Follmann, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055873/
https://www.ncbi.nlm.nih.gov/pubmed/33875654
http://dx.doi.org/10.1038/s41541-021-00312-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055873/
https://www.ncbi.nlm.nih.gov/pubmed/33875654
http://dx.doi.org/10.1038/s41541-021-00312-9

Ejemplares similares